Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Astra reveals novel opioid peptides

April 14, 1997

PEP inhibitors from Chinoin

April 14, 1997

Pfizer reports new salt of known NMDA antagonist

April 14, 1997

First launch for new indication of cabergoline

April 11, 1997

Synthelabo prepares serotonergic agents

April 11, 1997

Arzneimittelwerk describes novel antiepileptic agents

April 11, 1997

Astra prepares NOS inhibitors

April 11, 1997

Selective 5-HT1Dalpha receptor agonists from MS&D

April 11, 1997

Pharmacia & Upjohn discontinues roquinimex MS trials

April 10, 1997

New carbamate derivative from Kyorin with high affinity/selectivity for M1 receptors

April 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...